H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR PCT0025-01: FVIII TCR-ENGINEERED TREG CELL PRODUCT
Key Details
Description
PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR PCT0025-01: FVIII TCR-ENGINEERED TREG CELL PRODUCT
Context & Analysis
On Dec 1, 2025, Department of Health and Human Services obligated $761,385.23 to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. for production assistance for cellular therapies (pact)- cell processing facilities cell manufacturing and process development services for pct0025-01: fviii tcr-engineered treg cell product. The award is classified under NAICS 541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 1 offer received. Performance is located in TAMPA, FL. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541712 — related awards are listed below.
Contractor Information
Similar Awards
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NATIONAL TOXICOLOGY PROGRAM
RESEARCH TRIANGLE INSTITUTE
$54.3M
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NTP
MRIGLOBAL
$50.9M
IGF::CL::IGF WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER
FRED HUTCHINSON CANCER RESEARCH CENTER
$49.7M
IGF::OT::IGFCHEMISTRY SERVICES FOR THE NTP
BATTELLE MEMORIAL INSTITUTE
$43.2M
IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
BURLESON RESEARCH TECHNOLOGIES, INC.
$30.2M
Stay Updated
Get notified about new opportunities matching your interests.